| Literature DB >> 27184854 |
Lee Adam Wheeler1, Radiana T Trifonova2, Vladimir Vrbanac3, Natasha S Barteneva2, Xing Liu2, Brooke Bollman2, Lauren Onofrey2, Sachin Mulik2, Shahin Ranjbar2, Andrew D Luster3, Andrew M Tager3, Judy Lieberman4.
Abstract
Despite their antiviral effect, the in vivo effect of interferons on HIV transmission is difficult to predict, because interferons also activate and recruit HIV-susceptible cells to sites of infection. HIV does not normally induce type I interferons in infected cells, but does if TREX1 is knocked down. Here, we investigated the effect of topical TREX1 knockdown and local interferon production on HIV transmission in human cervicovaginal explants and humanized mice. In explants in which TREX1 was knocked down, HIV induced interferons, which blocked infection. In humanized mice, even though TREX1 knockdown increased infiltrating immune cells, it delayed viral replication for 3-4 weeks. Similarly intravaginal application of type I interferons the day before HIV infection induced interferon responsive genes, reduced inflammation, and decreased viral replication. However, intravenous interferon enhanced inflammation and infection. Thus, in models of human sexual transmission, a localized interferon response inhibits HIV transmission but systemic interferons do not.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27184854 PMCID: PMC4881429 DOI: 10.1016/j.celrep.2016.04.048
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423